Combes Alain
Service de réanimation médicale, institut de cardiologie, groupe hospitalier La Pitié-Salpêtrière, AP-HP, 75651 Paris Cedex 13, France.
Rev Prat. 2013 May;63(5):611-6.
Myocarditis is defined as inflammation of the myocardium accompanied by myocellular necrosis. Acute myocarditis must be considered in patients who present with recent onset of cardiac failure or arrhythmia. Fulminant myocarditis is a distinct entity characterized by sudden onset of severe congestive heart failure or cardiogenic shock, usually following a flu-like illness, parvovirus B19, human herpesvirus 6, coxsackievirus and adenovirus being the most frequently viruses responsible for the disease. Treatment of myocarditis remains largely supportive, since immunosuppression has not been proven to be beneficial for acute lymphocytic myocarditis. Trials of antiviral therapies, or immunostimulants such as interferons, suggest a potential therapeutic role but require further investigation. Lastly, early recognition of patients rapidly progressing to refractory cardiac failure and their immediate transfer to a medical-surgical center experienced in mechanical circulatory support is warranted. In this setting, ECMO should be the first-line mechanical assistance. For highly unstable patients, a Mobile Cardiac Assistance Unit, that rapidly travels to primary care hospitals with a portable ECMO system and hooks it up before refractory multiorgan failure takes hold, is the preferred option.
心肌炎的定义为伴有心肌细胞坏死的心肌炎症。对于近期出现心力衰竭或心律失常的患者,必须考虑急性心肌炎。暴发性心肌炎是一种特殊类型,其特征为严重充血性心力衰竭或心源性休克突然发作,通常在流感样疾病之后发生,细小病毒B19、人类疱疹病毒6、柯萨奇病毒和腺病毒是导致该疾病最常见的病毒。心肌炎的治疗在很大程度上仍以支持治疗为主,因为免疫抑制尚未被证明对急性淋巴细胞性心肌炎有益。抗病毒治疗试验或免疫刺激剂(如干扰素)显示出潜在的治疗作用,但需要进一步研究。最后,对于迅速进展为难治性心力衰竭的患者,应尽早识别并立即将其转至在机械循环支持方面经验丰富的内科-外科中心。在这种情况下,体外膜肺氧合(ECMO)应作为一线机械辅助手段。对于高度不稳定的患者,移动心脏辅助单元是首选,该单元可携带便携式ECMO系统迅速前往基层医院,并在难治性多器官功能衰竭发生之前连接好设备。